CN105770475A - Traditional Chinese medicine composition for treating angiitis - Google Patents
Traditional Chinese medicine composition for treating angiitis Download PDFInfo
- Publication number
- CN105770475A CN105770475A CN201610238616.1A CN201610238616A CN105770475A CN 105770475 A CN105770475 A CN 105770475A CN 201610238616 A CN201610238616 A CN 201610238616A CN 105770475 A CN105770475 A CN 105770475A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
Abstract
The invention discloses a traditional Chinese medicine composition for treating angiitis. The composition is prepared from, by weight, 30-100 parts of pangolin, 40-120 parts of pseudo-ginseng, 30-100 parts of radix cyathulae, 20-50 parts of myrrh, 30-70 parts of scorpion, 30-100 parts of spatholobus suberctu, 20-50 parts of mastiche, 25-90 parts of Angelica sinensis, 25-90 parts of Astragalus membranaceus, 20-80 parts of lumbricus, 20-80 parts of pawpaw, 20-80 parts of radix trichosanthis, 25-60 parts of dendrobe, 30-50 parts of garden balsam stems, 30-60 parts of dried bodies of ground beetle, 30-60 parts of dandelion, 20-80 parts of honeysuckle stems, 15-70 parts of white atractylodes rhizome, 15-70 parts of cortex lycii radicis, 15-70 parts of black swallowwort roots and 15-70 parts of radix glycyrrhizae. The traditional Chinese medicine composition has the effects of removing necrotic tissue, promoting granulations, promoting blood circulation to arrest pain, removing dampness and dispersing blood stasis, takes effect rapidly, and is good in curative effect, capable of healing the angiitis rapidly, high in curative effect, capable of relieving pain of a patient due to the fact that amputation is not needed, and capable of better assuring the safety of body health of a patient.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to one and treat vasculitic Chinese medicine composition.
Background technology
Vasculitis is medically known as " thromboangiitis obliterans ", it it is the allergic inflammation betiding blood vessel, caused tremulous pulse segmental stricture by inflammation or paralysis trace or front and back expanded, cause circulatory disorders and cause tissue and organ ischemia and produce a series of comprehensive platform symptom, arteriolar segmental stricture, obturation can be caused, make acra lose nutrition, ulcer, necrosis occur, even disable or dead because of heart and brain renal function failure.It it is a kind of more obstinate, peripheral vascular disease that amputation rate is high.Vasculitis has become " number one killer " of human health, just the health of common people in serious threat.
Doctor trained in Western medicine does not temporarily have specific medicament for immune vasculitic treatment the most both at home and abroad; still use the Drug therapys such as non-steroidal anti-inflammatory agent, immunosuppressant, nonsteriodal anti-inflammatory, anticoagulant or vasodilation; but the use of hormone often causes fatal side effect, and easily recurs after drug withdrawal.Thromboangiitis obliterans is attributed to " necrosis " category by Chinese medicine.The understanding that peripheral arterial is sick is so write by Huangdi's Internal Classics: " send out in toe, name day necrosis.Its shape is red black, stubbornly refuses to control.The most red black, the most extremely.Do not wane, suddenly cut it, the most dead." to the symptom feature in necrosis later stage, Index for diagnosis, Therapeutic Method description the most accurate.The method for the treatment of such as the domestic traditional Chinese medical science the most useful temperature sun is invigorated blood circulation, nourishing YIN for suppressing the hyperactive YANG, heat-clearing and toxic substances removing, oral decoction curative effect is indefinite, onset is slow.The domestic scholar of having uses the therapy of combining Chinese and Western medicine method based on the rightest Radix Salviae Miltiorrhizae Injection, but all without departing from hormone therapy, easily recurs after withdrawing hormone;Add and treat with differentiation of tcm or compound Salviae Miltiorrhizae, MAILUONING and injection are treated, these medicines can not the progress of fundamentally symptom management, do not suppress the effect of immune inflammation mainly due to them.
Summary of the invention
For solving the drawbacks described above that prior art exists, it is an object of the invention to provide one and treat vasculitic Chinese medicine composition, there is removing the necrotic tissue and promoting granulation, promoting blood circulation and stopping pain, the effect of dampness removing blood stasis dispelling, instant effect, good effect, cures fast, cure rate height, without amputation, patient can be alleviated painful, save limbs more from damage for patient healthy.
For achieving the above object, the technical solution used in the present invention is: the vasculitic Chinese medicine composition of this treatment, it is characterized in that being prepared by the crude drug of following weight parts: Squama Manis 30-100 part, Radix Notoginseng 40-120 part, Radix Cyathulae 30-100 part, Myrrha 20-50 part, Scorpio 30-70 part, Caulis Spatholobi 30-100 part, Olibanum 20-50 part, Radix Angelicae Sinensis 25-90 part, Radix Astragali 25-90 part, Pheretima 20-80 part, Fructus Chaenomelis 20-80 part, Radix Trichosanthis 20-80 part, Herba Dendrobii 25-60 part, Herba speranskiae tuberculatae 30-50 part, eupolyphaga 30-60 part, Herba Taraxaci 30-60 part, Radix Ophiopogonis Teng 20-80 part, Rhizoma Atractylodis Macrocephalae 15-70 part, Cortex Lycii 15-70 part, white 15-70 part, Radix Glycyrrhizae 15-70 part.
Preferably, the vasculitic Chinese medicine composition of this treatment, it is characterised in that prepared by the crude drug of following weight parts: Squama Manis 40 parts, Radix Notoginseng 50 parts, Radix Cyathulae 50 parts, Myrrha 30 parts, Scorpio 35 parts, Caulis Spatholobi 50 parts, Olibanum 30 parts, Radix Angelicae Sinensis 50 parts, the Radix Astragali 60 parts, Pheretima 50 parts, Fructus Chaenomelis 30 parts, Radix Trichosanthis 45 parts, Herba Dendrobii 50 parts, Herba speranskiae tuberculatae 35 parts, eupolyphaga 40 parts, Herba Taraxaci 50 parts, Radix Ophiopogonis Teng 45 parts, the Rhizoma Atractylodis Macrocephalae 30 parts, Cortex Lycii 40 parts, white 30 parts, 50 parts of Radix Glycyrrhizae.
The most all medicines are end, make honeyed pill, each 15-40 gram, 2 times on the one, the most bfore meals.Herba Alii fistulosi, beef and mutton, chicken, fish and Carnis Canitis are prohibited in treatment therebetween.
The present invention puts into practice through inventor and form decades, has removing the necrotic tissue and promoting granulation, promoting blood circulation and stopping pain, effect of dampness removing blood stasis dispelling.Squama Manis and Radix Notoginseng are monarch drug.Squama Manis, blood circulation promoting and dispersing pathogen accumulation;Stimulate the menstrual flow stimulating milk secretion;Eliminating carbuncle is burst hard.Main blood stasis amenorrhea;Lump in the abdomen;Rheumatic arthralgia;Agalactia;Carbuncle;Scrofula.For amenorrhea abdominal mass, galactostasis, carbuncle sore tumefacting virus, arthralgia, numbness contracture.Radix Notoginseng blood circulation promoting and blood stasis dispelling, subduing swelling and relieving pain, clots absorbing of promoting blood circulation, clots absorbing blood and hold back fresh blood.Radix Cyathulae, Myrrha, Scorpio, Caulis Spatholobi, Olibanum are ministerial drug.Radix Cyathulae eliminating blood stasis and inducing menstruation, easing joint movement, inducing diuresis for treating stranguria syndrome, draws all medicines descending.Myrrha, dissipating blood stasis analgesic therapy, detumescence and promoting granulation, control the pain of various stagnation of blood stasis.Scorpio, endogenous wind stopping spasmolytic, removing obstruction in the collateral to relieve pain, dispersing pathogen accumulation.Caulis Spatholobi cures mainly rheumatic arthralgia, numb hand and foot, promoting the circulation of blood of enriching blood, dredge the meridian passage.Olibanum, promoting blood circulation by removing wind, muscles and tendons relaxing to alleviate pain, perfume is pungent wanders away, and dissipates blood evacuation of pus, and ventilationization is stagnant.Adjuvant drug: Radix Angelicae Sinensis, the Radix Astragali, Pheretima, Fructus Chaenomelis, Radix Trichosanthis, Herba Dendrobii, Herba speranskiae tuberculatae, eupolyphaga, Herba Taraxaci, Radix Ophiopogonis Teng, the Rhizoma Atractylodis Macrocephalae, Cortex Lycii, white.Chinese angelica blood supplementing, invigorate blood circulation.Radix Astragali enhancing human body immunity function, protect the liver, diuresis, defying age, anti-stress effect.Pheretima has dredge the meridian passage, blood circulation promoting and blood stasis dispelling, prophylactic treatment cardiovascular and cerebrovascular disease, thrombolytic, thromboembolism preventing.Fructus Chaenomelis is warm in nature, sour in the mouth, enters liver, spleen channel;Have and help digestion, anthelmintic, heat clearing away, the effect dispeled the wind.Radix Trichosanthis clearing away heat-fire, promoting the production of body fluid to quench thirst, evacuation of pus is subsided a swelling.Herba Dendrobii cold is clear, can clearing away lung-heat, nourishing stomach-YIN, raw kidney water, benefit vital essence, reducing the asthenic fever, mutually fire and take the photograph vigour, kidney nourishing water and easing the affected liver is cloudy, its eliminating toxin and beautifying the skin, nourishing taste.Herba speranskiae tuberculatae, expelling wind and cold, relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation and stopping pain, priming penetrates meridians, blood vessels, sensible extremity.Eupolyphaga, promoting blood circulation to remove blood stasis, inducing menstruation to relieve menalgia, there is anticoagulation and to Fibrinolytic effect.Herba Taraxaci, heat-clearing and toxic substances removing, diuresis eliminating stagnation.Radix Ophiopogonis Teng, heat-clearing and toxic substances removing, dispelling wind dredging collateral.The Rhizoma Atractylodis Macrocephalae, invigorating the spleen and benefiting QI, dampness diuretic, anticoagulation, antibacterial action.Cortex Lycii, brings down a fever except the effect of steaming, and removing heat from blood is except effects such as steaming, lung heat clearing pathogenic fire reducing.In vain, clearing away heat and cooling blood, inducing diuresis for treating stranguria syndrome, detoxification sore treatment.Make medicine Radix Glycyrrhizae, heat-clearing and toxic substances removing coordinating the actions of various ingredients in a prescription.
Detailed description of the invention
Embodiment 1
One treats vasculitic Chinese medicine composition, it is characterised in that prepared by the crude drug of following weight parts: Squama Manis 30 parts, Radix Notoginseng 40 parts, Radix Cyathulae 30 parts, Myrrha 20 parts, Scorpio 30 parts, Caulis Spatholobi 30 parts, Olibanum 20 parts, Radix Angelicae Sinensis 25 parts, the Radix Astragali 25 parts, Pheretima 20 parts, Fructus Chaenomelis 20 parts, Radix Trichosanthis 20 parts, Herba Dendrobii 25 parts, Herba speranskiae tuberculatae 30 parts, eupolyphaga 30 parts, Herba Taraxaci 30 parts, Radix Ophiopogonis Teng 20 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, Cortex Lycii 15 parts, white 15 parts, 15 parts of Radix Glycyrrhizae.
Embodiment 2
One treats vasculitic Chinese medicine composition, it is characterised in that prepared by the crude drug of following weight parts: Squama Manis 40 parts, Radix Notoginseng 50 parts, Radix Cyathulae 50 parts, Myrrha 30 parts, Scorpio 35 parts, Caulis Spatholobi 50 parts, Olibanum 30 parts, Radix Angelicae Sinensis 50 parts, the Radix Astragali 60 parts, Pheretima 50 parts, Fructus Chaenomelis 30 parts, Radix Trichosanthis 45 parts, Herba Dendrobii 50 parts, Herba speranskiae tuberculatae 35 parts, eupolyphaga 40 parts, Herba Taraxaci 50 parts, Radix Ophiopogonis Teng 45 parts, the Rhizoma Atractylodis Macrocephalae 30 parts, Cortex Lycii 40 parts, white 30 parts, 50 parts of Radix Glycyrrhizae.
Embodiment 3
One treats vasculitic Chinese medicine composition, it is characterised in that prepared by the crude drug of following weight parts: Squama Manis 100 parts, Radix Notoginseng 120 parts, Radix Cyathulae 100 parts, Myrrha 50 parts, Scorpio 70 parts, Caulis Spatholobi 100 parts, Olibanum 50 parts, Radix Angelicae Sinensis 90 parts, the Radix Astragali 90 parts, Pheretima 80 parts, Fructus Chaenomelis 80 parts, Radix Trichosanthis 80 parts, Herba Dendrobii 60 parts, Herba speranskiae tuberculatae 50 parts, eupolyphaga 60 parts, Herba Taraxaci 60 parts, Radix Ophiopogonis Teng 80 parts, the Rhizoma Atractylodis Macrocephalae 70 parts, Cortex Lycii 70 parts, white 70 parts, 70 parts of Radix Glycyrrhizae.
Pharmacodynamic experiment:
One, the standard of case selection:
1, multiple takayasu arteritis 49 example, wherein male 36 example, women 13 example, at minimum 31 years old of age, maximum 55 years old, the course of disease was the shortest 3 years, the longest 25 years.
2, thromboangiitis obliterans 26 example, wherein male 7 example, women 19 example, at minimum 35 years old of age, maximum 54 years old, the course of disease was the shortest 5 years, the longest 20 years.
3, thrombophlebitis 16 example, wherein male 6 example, women 10 example, at minimum 42 years old of age, maximum 62 years old, the course of disease was the shortest 10 years, the longest 30 years.
4, limb artery hardening obliterans 11 example, wherein male 5 example, women 6 example, at minimum 51 years old of age, maximum 63 years old, the course of disease was the shortest 8 years, the longest 35 years.
Two, the diagnostic criteria of disease:
1, multiple takayasu arteritis: brain, limb ischemia, renal hypertension, vascular murmur, Fundus oculi changes, low grade fever, arthralgia.
2, thromboangiitis obliterans: pain, send out cool and paraesthesia, skin color are pale or aubergine.
3, thrombophlebitis: limbs obvious tumefaction, pain, variable color.
4, limb artery hardening obliterans: limbs heating, intermittent claudication, acro-ischemia necrosis.
Three, medication:
15-40 gram every time, 2 times on the one, the most bfore meals.
Four, the criterion of curative effect:
1, recovery from illness: active stage performance disappears, and ischemia symptom and sign are wholly absent.
2, effective: active stage performance disappears, and ischemia symptom and sign are clearly better.
3, effective: active stage performance disappears, and ischemia symptom and sign turn for the better by and large.
4, invalid: sings and symptoms does not change.
Five, efficacy result analysis:
Case | Number | Recovery from illness (%) | Effective (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
Multiple takayasu arteritis | 49 | 19(28.8) | 22(44.9) | 7(14.3) | 1(2.0) | 97.9 |
Thromboangiitis obliterans | 26 | 11(42.3) | 9(34.6) | 5(19.2) | 1(3.8) | 96.2 |
Thrombophlebitis | 16 | 9(56.3) | 4(25) | 2(12.5) | 1(6.3) | 93.8 |
Limb artery hardening obliterans | 11 | 5(45.5) | 3(27.3) | 1(9.1) | 2(18.2) | 81.8 |
Claims (2)
1. treat vasculitic Chinese medicine composition for one kind, it is characterized in that being prepared by the crude drug of following weight parts: Squama Manis 30-100 part, Radix Notoginseng 40-120 part, Radix Cyathulae 30-100 part, Myrrha 20-50 part, Scorpio 30-70 part, Caulis Spatholobi 30-100 part, Olibanum 20-50 part, Radix Angelicae Sinensis 25-90 part, Radix Astragali 25-90 part, Pheretima 20-80 part, Fructus Chaenomelis 20-80 part, Radix Trichosanthis 20-80 part, Herba Dendrobii 25-60 part, Herba speranskiae tuberculatae 30-50 part, eupolyphaga 30-60 part, Herba Taraxaci 30-60 part, Radix Ophiopogonis Teng 20-80 part, Rhizoma Atractylodis Macrocephalae 15-70 part, Cortex Lycii 15-70 part, white 15-70 part, Radix Glycyrrhizae 15-70 part.
2. the vasculitic Chinese medicine composition for the treatment of as claimed in claim 1, it is characterised in that prepared by the crude drug of following weight parts: Squama Manis 40 parts, Radix Notoginseng 50 parts, Radix Cyathulae 50 parts, Myrrha 30 parts, Scorpio 35 parts, Caulis Spatholobi 50 parts, Olibanum 30 parts, Radix Angelicae Sinensis 50 parts, the Radix Astragali 60 parts, Pheretima 50 parts, Fructus Chaenomelis 30 parts, Radix Trichosanthis 45 parts, Herba Dendrobii 50 parts, Herba speranskiae tuberculatae 35 parts, eupolyphaga 40 parts, Herba Taraxaci 50 parts, Radix Ophiopogonis Teng 45 parts, the Rhizoma Atractylodis Macrocephalae 30 parts, Cortex Lycii 40 parts, white 30 parts, 50 parts of Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610238616.1A CN105770475A (en) | 2016-04-18 | 2016-04-18 | Traditional Chinese medicine composition for treating angiitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610238616.1A CN105770475A (en) | 2016-04-18 | 2016-04-18 | Traditional Chinese medicine composition for treating angiitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105770475A true CN105770475A (en) | 2016-07-20 |
Family
ID=56397663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610238616.1A Pending CN105770475A (en) | 2016-04-18 | 2016-04-18 | Traditional Chinese medicine composition for treating angiitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105770475A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084398A (en) * | 1992-11-23 | 1994-03-30 | 李治田 | Pill for supplementing qi and invigorating vasculum |
CN1569116A (en) * | 2004-05-13 | 2005-01-26 | 哈尔滨康信药物技术开发有限公司 | Angitis treating medicine |
CN101002917A (en) * | 2006-11-04 | 2007-07-25 | 于曼秋 | Chinese medicine for treating thromboangitis obliterans |
CN101053632A (en) * | 2006-04-13 | 2007-10-17 | 吴希文 | Traditional Chinese medicine for treating thromboangitis obliterans |
CN101229221A (en) * | 2008-01-04 | 2008-07-30 | 张锡贵 | Chinese traditional medicine for treating thromboangiitis obliterans and preparing method thereof |
CN103845385A (en) * | 2014-03-27 | 2014-06-11 | 靳老脏 | External medicament for treating angiitis |
-
2016
- 2016-04-18 CN CN201610238616.1A patent/CN105770475A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084398A (en) * | 1992-11-23 | 1994-03-30 | 李治田 | Pill for supplementing qi and invigorating vasculum |
CN1569116A (en) * | 2004-05-13 | 2005-01-26 | 哈尔滨康信药物技术开发有限公司 | Angitis treating medicine |
CN101053632A (en) * | 2006-04-13 | 2007-10-17 | 吴希文 | Traditional Chinese medicine for treating thromboangitis obliterans |
CN101002917A (en) * | 2006-11-04 | 2007-07-25 | 于曼秋 | Chinese medicine for treating thromboangitis obliterans |
CN101229221A (en) * | 2008-01-04 | 2008-07-30 | 张锡贵 | Chinese traditional medicine for treating thromboangiitis obliterans and preparing method thereof |
CN103845385A (en) * | 2014-03-27 | 2014-06-11 | 靳老脏 | External medicament for treating angiitis |
Non-Patent Citations (2)
Title |
---|
刘莉等: "自拟"清髓愈疽丹"治疗血栓闭塞性脉管炎38例临床观察", 《内蒙古中医药》 * |
张雅洁等: "中医治疗外周血管疾病的思路与方法", 《中医杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100341545C (en) | Oral medicine for treating thromboangitis obliterans | |
CN102319327B (en) | Traditional Chinese medicine for internally and externally treating diabetic foot | |
CN102961729A (en) | Externally-used traditional Chinese medicine for treating varicosity, thromboangiitis obliterans and phlebitis | |
CN106266896A (en) | A kind of invigorating primordial QI, kidney invigorating and YANG supporting, bone and muscle strengthening, the pill of curing rheumatism | |
CN1247233C (en) | Chinese medicine for varicose vein | |
CN102743556A (en) | Preparation method of Chinese medicine irrigation solution for treating hemorrhagic mycotic vaginitis | |
CN102824622B (en) | Preparation method of traditional Chinese medicine lotion for treating closed fracture with syndrome of palpitation | |
CN104689132A (en) | Traditional Chinese medicine composition for treating psoriasis | |
CN101249200B (en) | Chinese medicine lotion preparation for curing shallow wounds | |
CN101912552B (en) | Chinese medicinal preparation for treating ulcus cruris | |
CN102614479B (en) | Traditional Chinese medicine lotion preparation method for curing kidney-yang deficiency ecthyma | |
CN105561272A (en) | Traditional Chinese medicine preparation for relieving Reynolds disease and preparation method thereof | |
CN109908245A (en) | It is a kind of for treating the Chinese medicine composition of neck-shoulder pain, lumbago and leg pain disease | |
CN105770475A (en) | Traditional Chinese medicine composition for treating angiitis | |
CN104288604B (en) | A kind of Chinese medicine composition for treating cerebral infarction | |
CN111265644A (en) | Bone-activating pain-relieving plaster and preparation method thereof | |
CN103893606B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
CN110251645A (en) | A kind of logical prevention and treatment athlete's foot medical fluid of Chinese medicine blood vessel | |
CN102824421A (en) | Method for preparing Chinese medicinal lotion for treating surprised type closed fracture | |
CN102824537B (en) | Method of preparing traditional Chinese medicine lotion for treating stomach anorexia type closed fracture | |
CN102824546B (en) | Method for preparing traditional Chinese medicinal lotion for treating closed fracture due to deficiency of kidney yin | |
CN106421514A (en) | Traditional Chinese medicine for treating arthralgia | |
CN106110215A (en) | A kind of medicine treating varicose veins of the lower extremity | |
CN105497817A (en) | Chinese herbal preparation for treating turgescence caused by trauma of ankle joint and preparation method thereof | |
CN105617214A (en) | Traditional Chinese medicine composition for treating scabies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160720 |